Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page
- Check4 days agoChange DetectedVersion update: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedVersion label updated from v3.4.1 to v3.4.2 in the page footer.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded a Lancet HIV 2021 96-week results publication citation with revision note (v3.4.1) and removed the Lancet HIV erratum reference with revision (v3.4.0).SummaryDifference0.0%

- Check40 days agoChange DetectedUI/metadata updates were applied: a Show glossary option was added, and the page now displays a Last Update Submitted that Met QC Criteria field along with a Revision indicator (v3.4.0). The older QC Criteria label (Last Update Submitted that met QC Criteria) and the No FEAR Act data label were removed, and capitalization of FEAR Act data was adjusted.SummaryDifference0.1%

- Check47 days agoChange DetectedA new 'Last Update Posted' field was added to the Study Details page. The 'Last Update Posted (Estimated)' field was removed.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.3.4 deployed; no visible updates to study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.